{
    "id": 23016,
    "fullName": "KIT T417_D419delinsI",
    "impact": "deletion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KIT T417_D419delinsI results in the deletion of 3 amino acids in the Ig-like C2-type domain 5 of the Kit protein from amino acids 417 to 419, combined with the insertion of an Isoleucine (I) at the same site (UniProt.org). T417_D419delinsI results in constitutive ligand-independent phosphorylation of Kit in cell culture in one study (PMID: 16015387) and therefore, is predicted to lead to a gain of Kit protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 5820,
                    "pubMedId": 16015387,
                    "title": "Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16015387"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "T417_D419delinsI",
    "createDate": "06/08/2016",
    "updateDate": "09/17/2018",
    "referenceTranscriptCoordinates": {
        "id": 136660,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54723601_54723609delinsATC",
        "cDna": "c.1249_1257delinsATC",
        "protein": "p.T417_D419delinsI",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14358,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT T417_D419delinsI were sensitive to treatment with Sutent (sunitinib), demonstrating decreased cell proliferation (PMID: 24205792).",
            "molecularProfile": {
                "id": 23697,
                "profileName": "KIT T417_D419delinsI"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 663,
                    "pubMedId": 24205792,
                    "title": "Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24205792"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 14357,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT T417_D419delinsI were sensitive to treatment with Flumatinib, demonstrating decreased cell proliferation (PMID: 24205792).",
            "molecularProfile": {
                "id": 23697,
                "profileName": "KIT T417_D419delinsI"
            },
            "therapy": {
                "id": 3169,
                "therapyName": "Flumatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 663,
                    "pubMedId": 24205792,
                    "title": "Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24205792"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6775,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib mesylate) inhibited Kit phosphorylation in transformed cells over expressing KIT T417_D419delinsI in culture (PMID: 16015387).",
            "molecularProfile": {
                "id": 23697,
                "profileName": "KIT T417_D419delinsI"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "conflicting",
            "references": [
                {
                    "id": 5820,
                    "pubMedId": 16015387,
                    "title": "Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16015387"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 14356,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT T417_D419delinsI were resistant to treatment with Gleevec (imatinib) in culture (PMID: 24205792).",
            "molecularProfile": {
                "id": 23697,
                "profileName": "KIT T417_D419delinsI"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "conflicting",
            "references": [
                {
                    "id": 663,
                    "pubMedId": 24205792,
                    "title": "Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24205792"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23697,
            "profileName": "KIT T417_D419delinsI",
            "profileTreatmentApproaches": [
                {
                    "id": 8962,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT T417_D419delinsI"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 136661,
            "transcript": "NM_001093772",
            "gDna": "chr4:g.54723601_54723609delinsATC",
            "cDna": "c.1249_1257delinsATC",
            "protein": "p.T417_D419delinsI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136660,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54723601_54723609delinsATC",
            "cDna": "c.1249_1257delinsATC",
            "protein": "p.T417_D419delinsI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136663,
            "transcript": "XM_017008180",
            "gDna": "chr4:g.54723601_54723609delinsATC",
            "cDna": "c.1249_1257delinsATC",
            "protein": "p.T417_D419delinsI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136662,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54723601_54723609delinsATC",
            "cDna": "c.1249_1257delinsATC",
            "protein": "p.T417_D419delinsI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}